Phosphoinositide-dependent kinase 1 regulates leukemia stem cell maintenance in MLL-AF9-induced murine acute myeloid leukemia

Biochemical and Biophysical Research Communications
Tianyuan HuWeiping Yuan

Abstract

Although great efforts have been made to improve available therapies, the mortality rate of acute myeloid leukemia (AML) remains high due to poor treatment response and frequent relapse after chemotherapy. Leukemia stem cells (LSCs) are thought to account for this poor prognosis and relapse. Phosphoinositide-dependent kinase 1 (PDK1) is a critical regulator of the PI3K/Akt pathway and has been shown to be frequently activated in leukemia. However, the role of PDK1 in the regulation of LSCs in AML is still not clear. Using a PDK1 conditional deletion MLL-AF9 murine AML model, we revealed that the deletion of PDK1 prolonged the survival of AML mice by inducing LSC apoptosis. This was accompanied by the increased expression of the pro-apoptotic genes Bax and p53 and the reduced expression of Stat5, which has been shown to be constitutively activated in leukemia. Thus, our findings suggest that PDK1 plays an essential role in maintaining LSCs. Further delineating the function of PDK1 in LSCs may provide a new strategy for the improved treatment of AML relapse.

References

Sep 8, 1995·Science·R KühnK Rajewsky
Nov 4, 1994·Science·S W LoweT Jacks
May 18, 2001·Best Practice & Research. Clinical Haematology·B Löwenberg
Jul 12, 2002·The EMBO Journal·Margaret A LawlorDario R Alessi
Feb 18, 2004·Nature Reviews. Cancer·Hua Yu, Richard Jove
Aug 13, 2004·The New England Journal of Medicine·Catriona H M JamiesonIrving L Weissman
Feb 19, 2005·Science·D D SarbassovDavid M Sabatini
Oct 26, 2005·Current Biology : CB·Jose R BayascasDario R Alessi
Jul 3, 2007·Cell·Brendan D Manning, Lewis C Cantley
Aug 12, 2008·Seminars in Oncology·Claudia SchollStefan Fröhling
Aug 21, 2009·Nature Reviews. Cancer·Mark B MeadsWilliam S Dalton
Sep 21, 2010·Breast Cancer Research : BCR·Chien-Chung ChenLewis A Chodosh
Dec 24, 2010·JAMA : the Journal of the American Medical Association·Andrew J GentlesAsh A Alizadeh
May 17, 2011·Current Medicinal Chemistry·C Raimondi, M Falasca

❮ Previous
Next ❯

Citations

Feb 28, 2018·Journal of Hematology & Oncology·Lulu LiuYan Zhang
Oct 25, 2017·Cancers·Aikaterini Emmanouilidi, Marco Falasca
Jul 10, 2020·International Journal of Molecular Sciences·Hee Jun ChoHaiyoung Jung
Mar 16, 2021·Critical Reviews in Oncology/hematology·Ana Carolina B da C RodriguesDaniel P Bezerra

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.